BIOMAT Database Logo BIOMAT Database Logo

Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission. 1993

J R Fiore, and M Jansson, and G Scarlatti, and G Angarano, and S L Caputo, and G Buccoliero, and P Rossi, and E M Fenyö, and G Pastore
Clinic of Infectious Diseases, University of Bari, Italy.

OBJECTIVE To evaluate the correlation between seroreactivity to peptides corresponding to the V3 loop of the major envelope glycoprotein from different HIV-1 strains and the risk of heterosexual HIV-1 transmission. METHODS Sera from 39 infected individuals (16 transmitters and 23 non-transmitters) were tested for reactivity against synthetic peptides representing sequences of the V3 loop apex from HIV-1 strains MN, SC, WMJ2, RF and IIIB. RESULTS A skewed distribution in seroreactivity to RF and IIIB peptides was observed between the two groups: reactivity was more prevalent in sera from non-transmitting than from transmitting individuals. Reactivity to the MN, SC and WMJ2 peptides was very frequent and there were no differences between the two groups. CONCLUSIONS These data suggest that antibodies reactive with a larger set of V3 apex peptides (i.e., cross-reactive antibodies) could play a role in the prevention of heterosexual transmission.

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D012725 Sexual Behavior Sexual activities of humans. Anal Sex,Oral Sex,Sexual Activity,Sexual Orientation,Premarital Sex Behavior,Sex Behavior,Sex Orientation,Sexual Activities,Activities, Sexual,Activity, Sexual,Behavior, Premarital Sex,Behavior, Sex,Behavior, Sexual,Orientation, Sexual,Sex, Anal,Sex, Oral
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015488 HIV Antigens Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens. AIDS Antigens,HIV-Associated Antigens,HTLV-III Antigens,HTLV-III-LAV Antigens,LAV Antigens,Lymphadenopathy-Associated Antigens,T-Lymphotropic Virus Type III Antigens, Human,HIV Associated Antigens,HTLV III Antigens,HTLV III LAV Antigens,Lymphadenopathy Associated Antigens,T Lymphotropic Virus Type III Antigens, Human,Antigens, AIDS,Antigens, HIV,Antigens, HIV Associated,Antigens, HIV-Associated,Antigens, HTLV III,Antigens, HTLV-III,Antigens, HTLV-III-LAV,Antigens, LAV,Antigens, Lymphadenopathy Associated,Antigens, Lymphadenopathy-Associated,Associated Antigens, HIV,Associated Antigens, Lymphadenopathy,III Antigens, HTLV

Related Publications

J R Fiore, and M Jansson, and G Scarlatti, and G Angarano, and S L Caputo, and G Buccoliero, and P Rossi, and E M Fenyö, and G Pastore
Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study.
October 1991, AIDS (London, England),
J R Fiore, and M Jansson, and G Scarlatti, and G Angarano, and S L Caputo, and G Buccoliero, and P Rossi, and E M Fenyö, and G Pastore
Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission.
January 1992, Journal of acquired immune deficiency syndromes,
J R Fiore, and M Jansson, and G Scarlatti, and G Angarano, and S L Caputo, and G Buccoliero, and P Rossi, and E M Fenyö, and G Pastore
Seroreactivity to HIV-1 V3 subtypes A to H peptides of Argentinian HIV-positive sera.
February 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
J R Fiore, and M Jansson, and G Scarlatti, and G Angarano, and S L Caputo, and G Buccoliero, and P Rossi, and E M Fenyö, and G Pastore
Female-to-male transmission of HIV-1.
October 1989, Lancet (London, England),
J R Fiore, and M Jansson, and G Scarlatti, and G Angarano, and S L Caputo, and G Buccoliero, and P Rossi, and E M Fenyö, and G Pastore
Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV.
March 1992, BMJ (Clinical research ed.),
J R Fiore, and M Jansson, and G Scarlatti, and G Angarano, and S L Caputo, and G Buccoliero, and P Rossi, and E M Fenyö, and G Pastore
[Male circumcision and HIV heterosexual transmission].
October 2003, Revista de saude publica,
J R Fiore, and M Jansson, and G Scarlatti, and G Angarano, and S L Caputo, and G Buccoliero, and P Rossi, and E M Fenyö, and G Pastore
Characteristic of HIV-1 in V3 loop region based on seroreactivity and amino acid sequences in Thailand.
June 2002, Asian Pacific journal of allergy and immunology,
J R Fiore, and M Jansson, and G Scarlatti, and G Angarano, and S L Caputo, and G Buccoliero, and P Rossi, and E M Fenyö, and G Pastore
[HIV-1, V3-loop binding protein(s) (V3-LBP)].
September 1993, Nihon rinsho. Japanese journal of clinical medicine,
J R Fiore, and M Jansson, and G Scarlatti, and G Angarano, and S L Caputo, and G Buccoliero, and P Rossi, and E M Fenyö, and G Pastore
Recognition properties of V3-specific antibodies to V3 loop peptides derived from HIV-1 gp120 presented in multiple conformations.
September 2000, Biochemistry,
J R Fiore, and M Jansson, and G Scarlatti, and G Angarano, and S L Caputo, and G Buccoliero, and P Rossi, and E M Fenyö, and G Pastore
Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission.
September 1995, Pediatric research,
Copied contents to your clipboard!